The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States Michael P. Harlander-Locke, BS, Liv K. Harmon, MD, Peter F. Lawrence, MD, Gustavo S. Oderich, MD, Robert A. McCready, MD, Mark D. Morasch, MD, Robert J. Feezor, MD Journal of Vascular Surgery Volume 59, Issue 3, Pages 669-674.e1 (March 2014) DOI: 10.1016/j.jvs.2013.09.009 Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 1 Kaplan-Meier analysis of freedom from cryopreserved aortoiliac allograft (CAA)-related complications. Journal of Vascular Surgery 2014 59, 669-674.e1DOI: (10.1016/j.jvs.2013.09.009) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 2 Kaplan-Meier analysis of patient survival, cryopreserved aortoiliac allograft (CAA) primary patency, and freedom from limb loss. Journal of Vascular Surgery 2014 59, 669-674.e1DOI: (10.1016/j.jvs.2013.09.009) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 3 Kaplan-Meier analysis of freedom from cryopreserved aortoiliac allograft (CAA) explant. Journal of Vascular Surgery 2014 59, 669-674.e1DOI: (10.1016/j.jvs.2013.09.009) Copyright © 2014 Society for Vascular Surgery Terms and Conditions